Biomemory
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- $22M
Investors
- 10
About Biomemory
a. Biomemory is a biotech company that creates DNA data synthesis and storage solutions capable of storing data with 1-million higher density than any SSD or magnetic tape to help meet the climate challenges posed by data centers. The company is developing petrol-free DNA synthesis and copy processes based on synthetic biology. Biomemory is also utilizing its proprietary technologies to develop long, bio-sourced, biocompatible, and bio-secure DNA fragments that can be stored as inert polymers for thousands of years without any energy input.
Who invested in Biomemory
10 investors across 2 rounds
See all investors in Biomemory
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biomemory
Who invested in Biomemory?
Biomemory has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biomemory raised?
Biomemory has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Biomemory last raise money?
Biomemory's most recent round on record is a Series A, in Jan 2024.
What does Biomemory do?
Biomemory is a biotechnology company.
Where is Biomemory headquartered?
Biomemory is headquartered in Paris, France.
Which VCs invest in companies like Biomemory?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Biomemory's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Biomemory? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.